Raptor Pharmaceutical to Attend Upcoming Conference NOVATO, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq: RPTP) today announced that Krishna Polu, M.D., Chief Medical Officer, will be a speaker at the following...

Raptor Pharmaceutical Announces Closing of Underwritten Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares NOVATO, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical company focused on developing and commercializing transformative treatments for people...

Raptor Pharmaceutical to Observe International Rare Disease Day Through Global Awareness Programs NOVATO, Calif., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced its support of Rare Disease Day on February 28, 2015 with a series of initiatives and events...

Raptor Submits IND for RP103 for Leigh Syndrome and Other Mitochondrial Disorders NOVATO, Calif., Dec. 10, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it has submitted an investigational new drug application (IND) to the U.S. Food and...